Corbus Pharmaceuticals Holdings, Inc. (CRBP)
8.12
-0.12
(-1.46%)
USD |
NASDAQ |
Sep 11, 16:00
10.41
+2.29
(+28.20%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Market Cap : 151.61M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 151.61M |
| September 10, 2026 | 153.85M |
| September 09, 2026 | 165.43M |
| September 08, 2026 | 197.82M |
| September 04, 2026 | 206.88M |
| September 03, 2026 | 213.98M |
| September 02, 2026 | 214.35M |
| September 01, 2026 | 210.61M |
| August 31, 2026 | 203.71M |
| August 28, 2026 | 203.71M |
| August 27, 2026 | 207.81M |
| August 26, 2026 | 210.99M |
| August 25, 2026 | 211.17M |
| August 24, 2026 | 199.60M |
| August 21, 2026 | 193.81M |
| August 20, 2026 | 183.73M |
| August 19, 2026 | 186.53M |
| August 18, 2026 | 188.21M |
| August 17, 2026 | 195.86M |
| August 14, 2026 | 188.40M |
| August 13, 2026 | 188.21M |
| August 12, 2026 | 182.23M |
| August 11, 2026 | 177.57M |
| August 10, 2026 | 176.63M |
| August 07, 2026 | 189.89M |
| Date | Value |
|---|---|
| August 06, 2026 | 181.86M |
| August 05, 2026 | 178.69M |
| August 04, 2026 | 175.51M |
| August 03, 2026 | 158.23M |
| July 31, 2026 | 159.12M |
| July 30, 2026 | 160.54M |
| July 29, 2026 | 158.23M |
| July 28, 2026 | 161.16M |
| July 27, 2026 | 161.07M |
| July 24, 2026 | 162.67M |
| July 23, 2026 | 165.33M |
| July 22, 2026 | 156.81M |
| July 21, 2026 | 159.30M |
| July 20, 2026 | 157.70M |
| July 17, 2026 | 159.83M |
| July 16, 2026 | 156.10M |
| July 15, 2026 | 159.83M |
| July 14, 2026 | 160.18M |
| July 13, 2026 | 160.36M |
| July 10, 2026 | 171.71M |
| July 09, 2026 | 171.36M |
| July 08, 2026 | 169.41M |
| July 07, 2026 | 166.39M |
| July 06, 2026 | 159.65M |
| July 02, 2026 | 164.08M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
| Anika Therapeutics, Inc. | 279.17M |
| Savara, Inc. | 1.089B |
| Vericel Corp. | 1.962B |
Market Cap Related Metrics
| PEG Ratio | -0.0443 |
| Price to Book Value | 1.483 |
| Price | 8.12 |
| Earnings Yield | -76.07% |
| PEGY Ratio | -0.0443 |